News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
280,257 Results
Type
Article (15336)
Company Profile (105)
Press Release (264808)
Multimedia
Podcasts (67)
Webinars (13)
Section
Business (89568)
Career Advice (768)
Deals (15610)
Drug Delivery (74)
Drug Development (37054)
Employer Resources (61)
FDA (6580)
Job Trends (6400)
News (153080)
Policy (14442)
Tag
2027 Genetown Elite (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (1)
Academia (512)
Accelerated approval (14)
Adcomms (8)
Allergies (72)
Alliances (23583)
ALS (56)
Alzheimer's disease (498)
Antibody-drug conjugate (ADC) (101)
Approvals (6762)
Artificial intelligence (213)
Autoimmune disease (47)
Automation (13)
Bankruptcy (152)
Best Places to Work (4501)
BIOSECURE Act (9)
Biosimilars (120)
Biotechnology (40)
Bladder cancer (38)
Brain cancer (31)
Breast cancer (175)
Cancer (1353)
Cardiovascular disease (156)
Career advice (667)
Career pathing (14)
CAR-T (53)
CDC (6)
Cell therapy (165)
Cervical cancer (9)
Clinical research (32279)
Collaboration (756)
Compensation (330)
Complete response letters (34)
COVID-19 (818)
CRISPR (45)
C-suite (460)
Cystic fibrosis (58)
Data (1867)
Denatured (19)
Depression (47)
Diabetes (128)
Diagnostics (1443)
Digital health (10)
Diversity (2)
Diversity, equity & inclusion (16)
Drug discovery (121)
Drug pricing (114)
Drug shortages (12)
Duchenne muscular dystrophy (82)
Earnings (33902)
Editorial (22)
Employer branding (5)
Employer resources (55)
Events (39553)
Executive appointments (541)
FDA (7708)
Fibrodysplasia Ossificans Progressiva (3)
Friedreich's ataxia (2)
Frontotemporal dementia (1)
Funding (453)
Gene editing (74)
Generative AI (20)
Gene therapy (184)
GLP-1 (454)
Government (1481)
Grass and pollen (4)
Guidances (168)
Healthcare (3834)
HIV (12)
Huntington's disease (10)
IgA nephropathy (39)
Immunology and inflammation (71)
Immuno-oncology (16)
Indications (55)
Infectious disease (885)
Inflammatory bowel disease (75)
Inflation Reduction Act (7)
Influenza (25)
Intellectual property (115)
Interviews (139)
IPO (6005)
IRA (33)
Job creations (2089)
Job search strategy (569)
JPM (32)
Kidney cancer (9)
Labor market (30)
Layoffs (214)
Leadership (14)
Legal (3524)
Liver cancer (24)
Longevity (8)
Lung cancer (185)
Lymphoma (125)
Machine learning (13)
Management (21)
Manufacturing (426)
MASH (72)
Medical device (1585)
Medtech (1592)
Mergers & acquisitions (10027)
Metabolic disorders (453)
Multiple sclerosis (48)
NASH (14)
Neurodegenerative disease (85)
Neuropsychiatric disorders (40)
Neuroscience (921)
Neurotech (1)
NextGen: Class of 2026 (1704)
Non-profit (699)
Now hiring (18)
Obesity (239)
Opinion (167)
Ovarian cancer (43)
Pain (110)
Pancreatic cancer (52)
Parkinson's disease (81)
Partnered (11)
Patents (226)
Patient recruitment (125)
Peanut (12)
People (30237)
Pharmaceutical (63)
Pharmacy benefit managers (18)
Phase 1 (8386)
Phase 2 (13645)
Phase 3 (12300)
Pipeline (2002)
Policy (143)
Postmarket research (1411)
Preclinical (3382)
Press Release (25)
Prostate cancer (87)
Psychedelics (17)
Radiopharmaceuticals (137)
Rare diseases (357)
Real estate (2717)
Recruiting (25)
Regulatory (11162)
Reports (15)
Research institute (616)
Resumes & cover letters (101)
Rett syndrome (5)
RNA editing (6)
RSV (20)
Schizophrenia (72)
Series A (83)
Series B (54)
Service/supplier (2)
Sickle cell disease (47)
Special edition (10)
Spinal muscular atrophy (82)
Sponsored (9)
Startups (1683)
State (2)
Stomach cancer (5)
Supply chain (49)
Tariffs (70)
The Weekly (46)
Vaccines (246)
Venture capital (36)
Weight loss (147)
Women's health (28)
Worklife (5)
Date
Today (39)
Last 7 days (218)
Last 30 days (724)
Last 365 days (10636)
2026 (1189)
2025 (10901)
2024 (12690)
2023 (14478)
2022 (19976)
2021 (20528)
2020 (19543)
2019 (15491)
2018 (12189)
2017 (14220)
2016 (13468)
2015 (15793)
2014 (12714)
2013 (10829)
2012 (11662)
2011 (12200)
2010 (11123)
Location
Africa (368)
Alabama (19)
Alaska (2)
Arizona (85)
Arkansas (3)
Asia (21196)
Australia (2792)
California (3248)
Canada (1532)
China (563)
Colorado (147)
Connecticut (133)
Delaware (130)
Europe (41645)
Florida (618)
Georgia (63)
Hawaii (1)
Idaho (12)
Illinois (359)
India (45)
Indiana (241)
Iowa (2)
Japan (252)
Kansas (77)
Kentucky (20)
Louisiana (4)
Maine (2)
Maryland (431)
Massachusetts (2646)
Michigan (79)
Minnesota (192)
Mississippi (1)
Missouri (37)
Montana (8)
Nebraska (7)
Nevada (16)
New Hampshire (8)
New Jersey (1418)
New Mexico (7)
New York (934)
North Carolina (632)
North Dakota (2)
Northern California (1480)
Ohio (83)
Oklahoma (5)
Oregon (21)
Pennsylvania (729)
Puerto Rico (14)
Rhode Island (17)
South America (566)
South Carolina (10)
Southern California (1418)
Tennessee (54)
Texas (466)
United States (13028)
Utah (63)
Virginia (164)
Washington D.C. (43)
Washington State (228)
West Virginia (1)
Wisconsin (39)
Wyoming (1)
280,257 Results for "sound pharmaceuticals".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Sound Pharmaceuticals Receives FDA Breakthrough Therapy Designation for SPI-1005 to Treat Meniere’s Disease
December 2, 2025
·
3 min read
Insights
From Sound Bites to Signals: Editors Parse Executive and Investor Chatter at JPM
In this episode of Denatured, BioSpace editorial team members, Senior Editor, Annalee Armstrong, and News Editor, Dan Samorodnitsky, discuss their post-JPM takeaways and 2026 forecasts after speaking to a range of pharma and biotech executives and investors last week.
January 22, 2026
·
1 min read
·
Jennifer Smith-Parker
Press Releases
BOOST Pharma Adds Sound Bioventures to Investor Syndicate with SEK 34 Million Investment to Advance Stem Cell Therapy for Osteogenesis Imperfecta
November 3, 2025
·
2 min read
Press Releases
Sound Pharma to Present at Upcoming Life Sciences Industry Conferences
July 9, 2025
·
2 min read
BioForest
Sound Pharmaceuticals’ IND Involving Cochlear Implantation Allowed by the FDA
Sound Pharmaceuticals (SPI) is pleased to announce that it has received FDA notification that its Investigational New Drug Application (IND) may proceed involving SPI-1005 treatment and cochlear implantation (CI).
May 20, 2024
·
3 min read
Press Releases
Sound Blade Medical Appoints Neil Barman, M.D. as Chief Executive Officer
August 1, 2025
·
2 min read
Government
100+ CEOs, Biopharma Leaders Sound Alarm on ‘Catastrophic’ Health Cuts
In an open letter addressing the Trump administration’s proposed budget cuts to HHS, the executives urged Congress to continue “robust federal funding” for scientific research, which they say will help maintain U.S. biotech leadership globally.
June 30, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Sound Pharma to Present at Upcoming Life Science Investor Conferences
April 8, 2025
·
2 min read
BioMidwest
NephroDI Therapeutics Announces Investment by Sound Bioventures to Accelerate Development of NDI-5001 as a Potential First-in-Class Therapy for Pediatric Orphan Kidney Disease
NephroDI Therapeutics (NephroDI), a near-clinical stage pharmaceutical company focusing on kidney disorders, announces a Series A investment from life sciences VC Sound Bioventures.
June 20, 2024
·
4 min read
Job Trends
Sounding Off: Political Climate, Job Market Have Some Eyeing Biopharma Work Abroad
Nearly a third of employed and almost half of unemployed
BioSpace
survey respondents are seriously considering leaving the U.S. to find biotech and pharma jobs. Concerns about how the political climate is affecting biopharma are a key driver for many.
May 29, 2025
·
5 min read
·
Angela Gabriel
1 of 28,026
Next
